Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin L Robb

Showing results (281-290 of 358) with videos related to

Pageof 36
Sort By:
Vaccines|May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical TrialJulie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Nature|November 15, 2016
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeysErica N Borducchi, Crystal Cabral, Kathryn E Stephenson, et al.
Plos Pathogens|February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMorgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
The Journal of Clinical Investigation|September 21, 2023
Initial productive and latent HIV infections originate in vivo by infection of resting T cellsStephen W Wietgrefe, Jodi Anderson, Lijie Duan, et al.
Nature|July 22, 2014
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeysJames B Whitney, Alison L Hill, Srisowmya Sanisetty, et al.
JCI Insight|December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infectionKelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.
Plos Pathogens|April 14, 2018
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV diseaseMarcus Buggert, Son Nguyen, Laura M McLane, et al.
Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.
The New England Journal of Medicine|February 9, 2022
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.SJerald Sadoff, Glenda Gray, An Vandebosch, et al.
Plos One|January 31, 2020
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South AfricansLue Ping Zhao, Andrew Fiore-Gartland, Lindsay N Carpp, et al.
Pageof 36

Showing results (281-290 of 358) with videos related to

Sort By:
Pageof 36
Vaccines|May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical TrialJulie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Nature|November 15, 2016
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeysErica N Borducchi, Crystal Cabral, Kathryn E Stephenson, et al.
Plos Pathogens|February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMorgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
The Journal of Clinical Investigation|September 21, 2023
Initial productive and latent HIV infections originate in vivo by infection of resting T cellsStephen W Wietgrefe, Jodi Anderson, Lijie Duan, et al.
Nature|July 22, 2014
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeysJames B Whitney, Alison L Hill, Srisowmya Sanisetty, et al.
JCI Insight|December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infectionKelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.
Plos Pathogens|April 14, 2018
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV diseaseMarcus Buggert, Son Nguyen, Laura M McLane, et al.
Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.
The New England Journal of Medicine|February 9, 2022
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.SJerald Sadoff, Glenda Gray, An Vandebosch, et al.
Plos One|January 31, 2020
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South AfricansLue Ping Zhao, Andrew Fiore-Gartland, Lindsay N Carpp, et al.
Pageof 36